Thereby, patients from all four cancer types could be segregated into low risk and high risk groups with significant log-rank p-values (Figure 8b), indicating that expression of the TGFβ-regulated EMT signature can be used to predict survival probability of cancer patients. This evidence concerns the gene TGFB1 and cancer.